Cargando…

Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials

BACKGROUND: Collagen-rich fibrous septae and subcutaneous adipose protrusions play a role in cellulite pathophysiology. Collagenase clostridium histolyticum-aaes (CCH-aaes) injection causes enzymatic release of septae to resolve cellulite depressions and create a skin smoothing effect. This analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Bass, Lawrence S., Kaufman-Janette, Joely, Joseph, John H., Kaminer, Michael S., Clark, James, Fabi, Sabrina G., Gold, Michael H., Katz, Bruce E., Peddy, Kappa, Schlessinger, Joel, Young, V. Leroy, Hurley, David, McLane, Michael P., Vijayan, Saji, Liu, Genzhou, Davis, Matthew W., Goldman, Mitchel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132528/
https://www.ncbi.nlm.nih.gov/pubmed/35646496
http://dx.doi.org/10.1097/GOX.0000000000004306
_version_ 1784713399295279104
author Bass, Lawrence S.
Kaufman-Janette, Joely
Joseph, John H.
Kaminer, Michael S.
Clark, James
Fabi, Sabrina G.
Gold, Michael H.
Katz, Bruce E.
Peddy, Kappa
Schlessinger, Joel
Young, V. Leroy
Hurley, David
McLane, Michael P.
Vijayan, Saji
Liu, Genzhou
Davis, Matthew W.
Goldman, Mitchel P.
author_facet Bass, Lawrence S.
Kaufman-Janette, Joely
Joseph, John H.
Kaminer, Michael S.
Clark, James
Fabi, Sabrina G.
Gold, Michael H.
Katz, Bruce E.
Peddy, Kappa
Schlessinger, Joel
Young, V. Leroy
Hurley, David
McLane, Michael P.
Vijayan, Saji
Liu, Genzhou
Davis, Matthew W.
Goldman, Mitchel P.
author_sort Bass, Lawrence S.
collection PubMed
description BACKGROUND: Collagen-rich fibrous septae and subcutaneous adipose protrusions play a role in cellulite pathophysiology. Collagenase clostridium histolyticum-aaes (CCH-aaes) injection causes enzymatic release of septae to resolve cellulite depressions and create a skin smoothing effect. This analysis pooled data from two identically designed, phase-3, randomized, double-blind, placebo-controlled studies to examine the efficacy and safety of CCH-aaes. METHODS: Adult women with moderate/severe cellulite (3–4 on Clinician Reported Photonumeric Cellulite Severity Scale and Patient Reported Photonumeric Cellulite Severity Scale) on the buttocks received up to three treatment sessions (Days 1, 22, and 43) of subcutaneous CCH-aaes 0.84 mg or placebo per treatment area. Composite and individual component response (≥2-level or ≥1-level improvement from baseline in Patient Reported Photonumeric Cellulite Severity Scale and/or Clinician Reported Photonumeric Cellulite Severity Scale) and additional patient-reported outcomes were determined at Day 71. RESULTS: Analysis included 424 CCH-aaes−treated and 419 placebo-treated women. CCH-aaes−treated women were 5.9 times more likely than placebo-treated women to be ≥2-level composite responders at Day 71 (odds ratio [95% confidence interval], 5.9 [2.2–15.4]; P < 0.001). A significantly greater percentage of CCH-aaes−treated women versus placebo-treated women were ≥1-level composite responders at Day 71 (39.4% versus 14.6%; P < 0.001). Subgroup analyses indicated no apparent impact of Fitzpatrick skin type category and baseline cellulite severity (moderate/severe) on CCH-aaes efficacy. An inverse relationship between age and CCH-aaes response was observed in those with a body mass index less than 32 kg per m(2). The most common adverse events with CCH-aaes were injection-site bruising and injection-site pain. CONCLUSION: CCH-aaes treatment significantly improved moderate-to-severe buttock cellulite appearance and was generally well tolerated.
format Online
Article
Text
id pubmed-9132528
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-91325282022-05-27 Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials Bass, Lawrence S. Kaufman-Janette, Joely Joseph, John H. Kaminer, Michael S. Clark, James Fabi, Sabrina G. Gold, Michael H. Katz, Bruce E. Peddy, Kappa Schlessinger, Joel Young, V. Leroy Hurley, David McLane, Michael P. Vijayan, Saji Liu, Genzhou Davis, Matthew W. Goldman, Mitchel P. Plast Reconstr Surg Glob Open Cosmetic BACKGROUND: Collagen-rich fibrous septae and subcutaneous adipose protrusions play a role in cellulite pathophysiology. Collagenase clostridium histolyticum-aaes (CCH-aaes) injection causes enzymatic release of septae to resolve cellulite depressions and create a skin smoothing effect. This analysis pooled data from two identically designed, phase-3, randomized, double-blind, placebo-controlled studies to examine the efficacy and safety of CCH-aaes. METHODS: Adult women with moderate/severe cellulite (3–4 on Clinician Reported Photonumeric Cellulite Severity Scale and Patient Reported Photonumeric Cellulite Severity Scale) on the buttocks received up to three treatment sessions (Days 1, 22, and 43) of subcutaneous CCH-aaes 0.84 mg or placebo per treatment area. Composite and individual component response (≥2-level or ≥1-level improvement from baseline in Patient Reported Photonumeric Cellulite Severity Scale and/or Clinician Reported Photonumeric Cellulite Severity Scale) and additional patient-reported outcomes were determined at Day 71. RESULTS: Analysis included 424 CCH-aaes−treated and 419 placebo-treated women. CCH-aaes−treated women were 5.9 times more likely than placebo-treated women to be ≥2-level composite responders at Day 71 (odds ratio [95% confidence interval], 5.9 [2.2–15.4]; P < 0.001). A significantly greater percentage of CCH-aaes−treated women versus placebo-treated women were ≥1-level composite responders at Day 71 (39.4% versus 14.6%; P < 0.001). Subgroup analyses indicated no apparent impact of Fitzpatrick skin type category and baseline cellulite severity (moderate/severe) on CCH-aaes efficacy. An inverse relationship between age and CCH-aaes response was observed in those with a body mass index less than 32 kg per m(2). The most common adverse events with CCH-aaes were injection-site bruising and injection-site pain. CONCLUSION: CCH-aaes treatment significantly improved moderate-to-severe buttock cellulite appearance and was generally well tolerated. Lippincott Williams & Wilkins 2022-05-25 /pmc/articles/PMC9132528/ /pubmed/35646496 http://dx.doi.org/10.1097/GOX.0000000000004306 Text en Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Cosmetic
Bass, Lawrence S.
Kaufman-Janette, Joely
Joseph, John H.
Kaminer, Michael S.
Clark, James
Fabi, Sabrina G.
Gold, Michael H.
Katz, Bruce E.
Peddy, Kappa
Schlessinger, Joel
Young, V. Leroy
Hurley, David
McLane, Michael P.
Vijayan, Saji
Liu, Genzhou
Davis, Matthew W.
Goldman, Mitchel P.
Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
title Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
title_full Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
title_fullStr Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
title_full_unstemmed Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
title_short Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
title_sort collagenase clostridium histolyticum-aaes for treatment of cellulite: a pooled analysis of two phase-3 trials
topic Cosmetic
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132528/
https://www.ncbi.nlm.nih.gov/pubmed/35646496
http://dx.doi.org/10.1097/GOX.0000000000004306
work_keys_str_mv AT basslawrences collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT kaufmanjanettejoely collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT josephjohnh collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT kaminermichaels collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT clarkjames collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT fabisabrinag collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT goldmichaelh collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT katzbrucee collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT peddykappa collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT schlessingerjoel collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT youngvleroy collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT hurleydavid collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT mclanemichaelp collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT vijayansaji collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT liugenzhou collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT davismattheww collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials
AT goldmanmitchelp collagenaseclostridiumhistolyticumaaesfortreatmentofcelluliteapooledanalysisoftwophase3trials